PUBBLICAZIONI RILEVANTI

ARTICOLI ORIGINALI PIU’ RILEVANTI (LEAD AUTHOR)

  1. Mocciaro G, George A, Allison M, Frontini M, Huang-Doran I, Reiman F, Gribble F, Vidal-Puig A, Griffin JL, Azzu V*, Kay R*, Vacca M*. Oxidised apolipoprotein peptidome characterises metabolic dysfunction-associated steatotic liver disease (MASLD). Liver International 2025 Feb;45(2):e16200. doi: 10.1111/liv.16200.Liver Int 2025 Feb;45(2):e16200. doi: 10.1111/liv.16200 - PMID: 39822152. * Last and corresponding authors.
  2. Vacca M*$, Kamzolas I*, Harder LM*, Oakley F, Trautwein C, Hatting M, Ross T, Bernardo B, Oldenburger A, Hjuler ST, Ksiazek I, Lindén D, Schuppan D, Rodriguez-Cuenca S, Tonini MM, Castañeda TR, Kannt A, Rodrigues CMP, Cockell S, Govaere O, Daly AK, Allison M, Honnens de Lichtenberg K, Kim YO, Lindblom A, Oldham S, Andréasson AC, Schlerman F, Marioneaux J, Sanyal A, Afonso MB, Younes R, Amano Y, Friedman SL, Wang S, Bhattacharya D, Simon E, Paradis V, Burt A, Grypari IM, Davies S, Driessen A, Yashiro H, Pors S, Worm Andersen M, Feigh M, Yunis C, Bedossa P, Stewart M, Cater HL, Wells S, Schattenberg JM, Anstee QM; LITMUS Investigators; Tiniakos D$, Perfield JW$, Petsalaki E$, Davidsen P$, Vidal-Puig A$. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nat Metab. 2024 Jun;6(6):1178-1196. doi: 10.1038/s42255-024-01043-6 - PMID: 38867022 - *Shared First Authors $Shared corresponding
  3. Mocciaro G, Allison M, Jenkins B, Azzu V, Huang-Doran I, Herrera-Marcos LV, Hall Z, Murgia A, Susan D, Frontini M, Vidal-Puig A, Koulman A*, Griffin JL*, Vacca M*. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol Metab 2023 Jul;73:101728. doi: 10.1016/j.molmet.2023.101728 - PMID: 37084865 *Corresponding Authors
  4. Mocciaro G, D'Amore S, Jenkins B, Kay R, Murgia A, Herrera-Marcos LV, Neun S, Sowton AP, Hall Z, Palma-Duran SA, Palasciano G, Reimann F, Murray A, Suppressa P, Sabbà C, Moschetta A, Koulman A, Griffin JL*, Vacca M*. Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome Int J Mol Sci 2022 Jun 17;23(12):6786. doi: 10.3390/ijms23126786 - PMID: 35743227 *Corresponding Authors
  5. Hall Z, Chiarugi D, Charidemou E, Leslie J, Scott E, Pellegrinet L, Allison M, Mocciaro G, Anstee QM, Evan GI, Hoare M, Vidal-Puig A, Oakley F, Vacca M*, Griffin JL*. Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma. Hepatology 2021 Mar;73(3):1028-1044. doi: 10.1002/hep.31391 - PMID: 32460431 *Last and Corresponding Authors
  6. Azzu V*, Vacca M*, Kamzolas I, Hall Z, Leslie J, Carobbio S, Virtue S, Davies SE, Lukasik A, Dale M, Bohlooly-Y M, Acharjee A, Lindén D. Bidault G, Petsalaki E, Griffin JL, Oakley F, Allison MED, Vidal-Puig A. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. Mol Metab 2021 Jun;48:101210. doi: 10.1016/j.molmet.2021.101210 - PMID: 33722690 *Joint first Authors
  7. Vacca M*, Leslie J, Virtue S, Lam BYH, Govaere O, Tiniakos D, Snow S, Davies S, Petkevicius K, Tong Z, Peirce V, Juul Nielsen M, Ament Z, Li W, Kostrzewski T, Leeming DJ, Ratziu V, Allison MED, Anstee QM, Griffin JL, Oakley F, Vidal-Puig A*. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nature Metabolism 2020 Jun;2(6):514-531. doi: 10.1038/s42255-020-0214-9 - PMID: 32694734 . *Corresponding Authors
  8. D’Amore S, Härdfeldt J, Cariello M, Graziano G, Copetti M, Di Tullio G, Piglionica M, Scialpi N, Sabbà C, Palasciano G, Vacca M*, Moschetta A*. Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome. Cardiovascular Research 2018 Jul 1;114(8):1154-1164. doi: 10.1093/cvr/cvy077 - PMID: 29584810 * Last & Corresponding Authors
  9. Salvia R, D'Amore S, Graziano G, Capobianco C, Sangineto M, Paparella D, de Bonfils P, Palasciano G, Vacca M*. Short-term benefits of an unrestricted-calorie traditional Mediterranean diet, modified with a reduced consumption of carbohydrates at evening, in overweight-obese patients. Int J Food Sci Nutr. 2017 Mar;68(2):234-248. doi: 10.1080/09637486.2016.1228100 - PMID: 27615385 * Corresponding author
  10. D'Amore S, Vacca M, Cariello M, Graziano G, D'Orazio A, Salvia R, Sasso RC, Sabbà C, Palasciano G, Moschetta A. Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil. Biochim Biophys Acta. 2016 Nov;1861(11):1671-1680. doi: 10.1016/j.bbalip.2016.07.003. - PMID: 27422371
  11. Vacca M, Di Eusanio M, Cariello M, Graziano G, D'Amore S, Dimitri Petridis F, D'Orazio A, Salvatore L, Tamburro A, Folesani G, Rutigliano D, Pellegrini F, Sabbà C, Palasciano G, Di Bartolomeo R, Moschetta A. Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis. Cardiovasc Res. 2016 Feb 1;109(2):228-39. doi: 10.1093/cvr/cvv266. - PMID: 26645979 (Editor’s Choice)
  12. Vacca M, D'Amore S, Graziano G, D'Orazio A, Cariello M, Massafra V, Salvatore L, Martelli N, Murzilli S, Lo Sasso G, Mariani-Costantini R, Moschetta A. Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. PLoS One. 2014 Aug 12;9(8):e104449. doi: 10.1371/journal.pone.0104449. - PMID: 25116592
  13. D'Amore S, Vacca M, Graziano G, D'Orazio A, Cariello M, Martelli N, Di Tullio G, Salvia R, Grandaliano G, Belfiore A, Pellegrini F, Palasciano G, Moschetta A. Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. Biochim Biophys Acta. 2013 Dec;1832(12):2289-301. doi: 10.1016/j.bbadis.2013.09.006. - PMID: 24060638
  14. Vacca M, Murzilli S, Salvatore L, Di Tullio G, D'Orazio A, Lo Sasso G, Graziano G, Pinzani M, Chieppa M, Mariani-Costantini R, Palasciano G, Moschetta A. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes. Gastroenterology 2013 Jun;144(7):1518-1529. doi: 10.1053/j.gastro.2013.02.027. - PMID: 23462179

REVIEWS PIU’ RILEVANTI (LEAD AUTHOR)

  1. Misceo D, Mocciaro G, D’Amore S*, Vacca M*. Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle Steatotic Liver Disease (SLD) and Hepatocellular carcinoma (HCC). Nutr Metab (Lond) 2024 Dec 23;21(1):112. doi: 10.1186/s12986-024-00871-3 - PMID: 39716321. * Last and corresponding authors.
  2. Leslie J, Geh D, Elsharkawy AM, Mann DA*, Vacca M*. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions J Hepatol 2022 Jul;77(1):219-236. doi: 10.1016/j.jhep.2022.01.029 - PMID: 35157957 * Last and corresponding authors
  3. Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. Gastroenterology 2020 May;158(7):1899-1912. doi: 10.1053/j.gastro.2019.12.054. - PMID: 32061598
  4. Vacca M*, Allison M, Griffin JL, Vidal-Puig A*. Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD. Semin Liver Dis. 2015 Aug;35(3):250-61. doi: 10.1055/s-0035-1562945. - PMID: 26378642. * Corresponding Author
  5. Vacca M, Degirolamo C, Massafra V, Polimeno L, Mariani-Costantini R, Palasciano G, Moschetta A. Nuclear receptors in regenerating liver and hepatocellular carcinoma. Mol Cell Endocrinol 2013 Apr 10;368(1-2):108-19. doi: 10.1016/j.mce.2012.06.025. - PMID: 22789748
  6. Vacca M, Degirolamo C, Mariani-Costantini R, Palasciano G, Moschetta A. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med Sep-Oct 2011;3(5):562-87. doi: 10.1002/wsbm.137. - PMID: 21755605

Bibliografia Completa, Links Esterni e Metriche: 

pubblicato il 19/10/2025 — ultima modifica 19/10/2025

Azioni sul documento